Cerebain Biotech Corp. Stock Price - CBBT

0.0004
0.00 (0.0%)
Best deals to access real time data!
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
Canna Trader Pro
Monthly Subscription
for only
$59.99
Small Cap Basic
Monthly Subscription
for only
$33.03
VAT not included
Company Name Stock Ticker Symbol Market Type
Cerebain Biotech Corp. (QB) CBBT OTC BB Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
0.00 0.0% 0.0004 0.00 0.00 0.00 0.0004 20:00:00
Bid Price Ask Price Spread Spread % News
0.0003 0.0004 0.00 0.0% - -
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 0.0004 USD

Cerebain Biotech Corp. Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 257.53k 643.83M $ -2.94M - - 4.04M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Cerebain Biotech Corp. News

Loading Messages....

Latest CBBT Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical CBBT Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.00040.00040.00030.00037693,526,5640.000.0%
1 Month0.00080.00080.0002350.00045589,210,141-0.0004-50.0%
3 Months0.00080.00130.0002350.000757311,510,800-0.0004-50.0%
6 Months0.001050.00180.0002350.000914413,136,740-0.00065-61.9%
1 Year0.0050.00570.0002350.001158218,732,731-0.0046-92.0%
3 Years0.44010.550.0002350.00207878,793,681-0.4397-99.91%
5 Years1.091.750.0002350.00233635,720,070-1.09-99.96%

Cerebain Biotech Corp. Description

Cerebain Biotech Corp. was incorporated on December 18, 2007 under the laws of Nevada. The Company is a smaller reporting biomedical company and through its wholly owned subsidiary, Cerebain Operating, Inc., the Company's business revolves around the discovery of products for the treatment of Alzheimer's disease utilizing Omentum. The Company plans to produce products that will include both a medical device solution as well as a synthetic drug solution.


Your Recent History
OTCBB
CBBT
Cerebain B..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.